SCHEMBL369530

SCHEMBL369530

Cn1cc(C(=O)CC(c2cccc(C(=O)NCCO)c2)c2ccc(Cl)cc2F)ccc1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CREBBP Q92793 1/20 0.37
SNCA P37840 1/20 0.36
F9 P00740 1/20 0.36
GPR52 Q9Y2T5 1/20 0.36
MAP2K2 P36507 1/20 0.35
MAP2K1 Q02750 1/20 0.35
BRD4 O60885 1/20 0.35
POLB P06746 1/20 0.35
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35
GPR139 Q6DWJ6 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
ATM Q13315 1/20 0.35
SLC6A9 P48067 1/20 0.35
SLC6A5 Q9Y345 1/20 0.35
GCG P01275 1/20 0.35
PKM P14618 1/20 0.35
TMEM97 Q5BJF2 1/20 0.34
SIGMAR1 Q99720 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL368098 0.91 GCG (0.39) SNCAGPR52MAP2K2MAP2K1POLB
SCHEMBL368824 0.90 CREBBP (0.35) CREBBPSNCAF9GPR52MAP2K2
SCHEMBL368826 0.90 CREBBP (0.35) CREBBPSNCAF9GPR52MAP2K2
SCHEMBL368825 0.90 CREBBP (0.35) CREBBPSNCAF9GPR52MAP2K2
SCHEMBL370670 0.88 CREBBP (0.43) CREBBPBRD4POLBMEN1KMT2A
SCHEMBL368926 0.84 BRD4 (0.35) CREBBPF9BRD4HTTMEN1
SCHEMBL1390349 0.83 BAZ2B (0.36) CREBBPBRD4MEN1KMT2A
SCHEMBL1390327 0.82 CREBBP (0.42) CREBBPBRD4POLBHPGDMEN1
SCHEMBL368555 0.82 GCG (0.37) CREBBPBRD4POLBHPGDHTT
SCHEMBL369981 0.82 EPHX2 (0.38) SNCAGCG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 CREBBP 2198/4885SNCA 2548/4885F9 4573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.